Skip to main page content
U.S. flag

An official website of the United States government

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2003 Dec 9;100(25):15047-52.
doi: 10.1073/pnas.2536517100. Epub 2003 Dec 1.

IL-27 regulates IL-12 responsiveness of naive CD4+ T cells through Stat1-dependent and -independent mechanisms

Sophie Lucas  1 , Nico Ghilardi, Ji Li, Frédéric J de Sauvage
Affiliations

IL-27 regulates IL-12 responsiveness of naive CD4+ T cells through Stat1-dependent and -independent mechanisms

Sophie Lucas et al. Proc Natl Acad Sci U S A. .

Abstract

IL-27, a novel heterodimeric cytokine produced by antigen-presenting cells, signals through the T cell cytokine receptor (TCCR)/WSX-1 expressed on naïve CD4+ T cells and natural killer cells. TCCR/WSX-1 deficiency results in delayed T helper type 1 (TH1) development through an unresolved mechanism. We report here that IL-27 stimulation in developing murine T helper cells potently induces the expression of the major TH1-specific transcription factor T-bet and its downstream target IL-12R beta2, independently of IFN gamma. In addition, IL-27 suppresses basal expression of GATA-3, the critical TH2-specific transcription factor that inhibits TH1 development by down-regulating signal transducer and activator of transcription (Stat) 4. IL-27 signaling through TCCR/WSX-1 induces phosphorylation of Stat1, Stat3, Stat4, and Stat5. Stat1 is required for suppression of GATA-3, but T-bet induction by IL-27 can also be mediated through a Stat1-independent pathway. Despite its TH1-like signaling profile, IL-27 is not sufficient to drive the differentiation of CD4+ T cells into IFN gamma-producing cells. Similarly, IL-27 induces T-bet expression in primary natural killer cells, but this does not result in an increase of IFN gamma production or cytotoxic activity. Therefore, although IL-27 is unable to drive IFN gamma production on its own, it plays an important role in the early steps of TH1 commitment by contributing in a paracrine manner to the control of IL-12 responsiveness.

PubMed Disclaimer

Figures

Fig. 1.
Fig. 1.
IL-27 induces Stat1, -3, -4, and -5 phosphorylation. CD4+ cells purified from TCCR+/+ or TCCR-/- splenocytes were treated with the indicated cytokines for 15 min in serum-free medium. Cell lysates were immunoprecipitated (IP) with Stat1 or Stat3 antibodies. Immunoprecipitates or cell lysates (for Stat4, -5, and -6 detection) were submitted to SDS/PAGE, followed by Western blotting (WB) with antibodies specific for the indicated phosphorylated Stat proteins. To control for equal protein loading, blots were stripped and reprobed with antibodies specific for the indicated total Stat proteins. Horizontal lines indicate the position of a 98-kDa marker.
Fig. 2.
Fig. 2.
IL-27 induces T-bet and IL-12R β2 and suppresses GATA-3 in developing CD4+ T cells. (A–C) CD4+ T cells purified from TCCR+/+ or TCCR-/- splenocytes were activated with plate-bound anti-CD3ε and anti-CD28 antibodies in the absence (white bars) or presence (gray bars) of IL-27 in TH1 conditions (IL-12 plus anti-IL-4 plus IL-2), TH2 conditions (IL-4 plus anti-IL-12 plus anti-IFNγ plus IL-2), or neutral (N) conditions (anti-IL-12 plus anti-IFNγ plus anti-IL-4 plus IL-2). Before activation or 48 h later, cells were collected for total RNA preparation. Levels of rpl19 (a ribosomal housekeeping gene), T-bet, IL-12R β2, and GATA-3 mRNAs were determined in duplicate by real-time RT-PCR and compared with levels measured in serial dilutions of a reference RNA. Results shown are arbitrary units normalized for rpl19 expression and are representative of three independent experiments. Error bars represent 1 SD. P values between data points that are discussed in the text as significantly different are <0.02. (A) T-bet mRNA levels. (B) IL-12R β2 mRNA levels. (C) GATA-3 mRNA levels. Fold suppressions between relevant samples are indicated. (D) CD4+ T cells purified from TCCR+/+ or TCCR-/- splenocytes were activated as in A–C. Forty-eight hours after activation, cells activated in the absence (filled gray histograms) or presence (open histograms) of mIL-27 were stained with anti-mCD4 and anti-mIL-12R β2 antibodies. Histograms are gated on live CD4+ cells.
Fig. 3.
Fig. 3.
IL-27-mediated induction of T-bet does not require Stat1, but IL-27-mediated suppression of GATA-3 is strictly dependent on Stat1. CD4+ T cells purified from Stat1+/+ or Stat1-/- splenocytes were activated as in Fig. 2 in the absence (white bars) or presence (gray bars) of IL-27. Before activation or 48 h later, cells were collected for total RNA preparation. Levels of rpl19, T-bet, IL-12R β2, and GATA-3 mRNAs were determined as indicated in Fig. 2. Results shown are arbitrary units normalized for rpl19 expression and are representative of two independent experiments. Fold inductions (for T-bet expression and IL-12R β2) or suppressions (for GATA-3 expression) between relevant samples are indicated. Error bars represent 1 SD. P values between data points that are discussed in the text as significantly different are <0.05. (A) T-bet mRNA levels. (B) IL-12R β2 mRNA levels. (C) GATA-3 mRNA levels.
Fig. 4.
Fig. 4.
IL-27 does not induce significantly the production of IFNγ by differentiated CD4+ T cells. CD4+ T cells purified from TCCR+/+ or TCCR-/- splenocytes were activated as in Fig. 2 in the indicated conditions in the absence (white bars) or presence (gray bars) of IL-27. Three days after activation, cells were expanded in medium containing mIL-2 only. Cells were collected on day 6 or 7 and washed, and 106 cells were restimulated with plate-bound anti-CD3ε antibodies. Cytokines secreted in the supernatant 24 h after restimulation were measured in duplicate by ELISA. (A) IFNγ production. (B) IL-4 production. Results shown are representative of three independent experiments.
Fig. 5.
Fig. 5.
Stat1 is not required for the IL-27-induced proliferation of CD4+ cells. CD4+ cells purified from Stat1+/+ (□) or Stat1-/- (▪) splenocytes were activated in triplicate wells with plate-bound anti-CD3ε and anti-CD28 antibodies in complete medium supplemented with anti-mIL-2 antibodies and increasing concentrations of mIL-27. [3H]Thymidine (1 μCi per well; 1 Ci = 37 GBq) was added during the last 24 h of this 3-day assay. Results are shown as the fold increase in [3H]thymidine incorporation in the presence of IL-27 compared with its absence (16,478 and 22,857 cpm in Stat1+/+ and Stat1-/- cells, respectively, in the absence of IL-27).
Fig. 6.
Fig. 6.
Effects of IL-27 on primary NK cells. (A) IL-27 does not induce the proliferation of primary NK cells. A total of 2 × 106 peripheral blood mononuclear cells from a healthy human donor were seeded in complete medium in the absence or presence of increasing concentrations of hIL-15 (□) or hIL-27 (•). Percentages of NK cells (CD56+/CD3- cells) were determined by FACS analysis before the initiation of the cultures and 7 days later, when cells were collected and counted. Results are indicated as the fold increase in total NK cell numbers in the presence of cytokines over the fold increase in the absence of cytokine (background: 0.54-fold in the absence of cytokine). (B) IL-27, like IL-12 and IL-15, induces T-bet expression in primary NK cells. DX5+ NK cells purified from TCCR+/+ (white bars) or TCCR-/- (gray bars) splenocytes were cultured in vitro for 44 h in the absence or presence of the indicated cytokines. Cells were collected for total RNA preparation, and rpl19 and T-bet mRNA levels were measured by real-time RT-PCR as indicated in Fig. 2. nd, not detectable. (C) IL-27, unlike IL-12 and IL-15, does not induce IFNγ production by primary NK cells. Supernatants from cultures of DX5+ TCCR+/+ NK cells described in B were collected after 44 h, and IFNγ production was measured by ELISA. nd, not detectable. (D) IL-27, unlike IL-12 and IL-15, does not increase the cytotoxic activity of primary NK cells. DX5+ NK cells purified from TCCR+/+ splenocytes were cultured in vitro for 18 h in the absence (⋄) or presence of mIL-27 (•), hIL-15 (□), or mIL-12 (▵). Cells were collected and incubated for 4 h with 51Cr-labeled NK-sensitive YAC-1 target cells at the indicated NK-to-target ratios. Specific lysis of YAC-1 cells was determined by measuring 51Cr released in the supernatants.
See this image and copyright information in PMC

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. Abbas, A. K., Murphy, K. M. & Sher, A. (1996) Nature 383, 787-793. - PubMed
    1. Mosmann, T. R. & Sad, S. (1996) Immunol. Today 17, 138-146. - PubMed
    1. O'Garra, A. (1998) Immunity 8, 275-283. - PubMed
    1. Murphy, K. M. & Reiner, S. L. (2002) Nat. Rev. Immunol. 2, 933-944. - PubMed
    1. Wurster, A. L., Tanaka, T. & Grusby, M. J. (2000) Oncogene 19, 2577-2584. - PubMed

Publication types

MeSH terms